financetom
Business
financetom
/
Business
/
Paramount closes $8 billion merger with Skydance after settling '60 Minutes' lawsuit
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Paramount closes $8 billion merger with Skydance after settling '60 Minutes' lawsuit
Aug 7, 2025 8:08 AM

(Reuters) -Paramount Global and Skydance Media have completed their $8.4 billion merger that was announced more than a year ago, the companies said, capping a long-drawn deal process marked by political scrutiny and shareholder concerns.

Renamed "Paramount Skydance Corp", the company's Class B shares will start trading on the Nasdaq under the ticker symbol PSKY from Thursday.

The merger brings together a major player in the industry with a sprawling global distribution network and a prized film and TV library, including classics such as "Breakfast at Tiffany's", with Skydance's production and technological capabilities.

"Today marks Day One of a new Paramount...the coming months will be defined by a series of focused efforts to re-engineer how our company operates, produces its creative content, and goes to market," said David Ellison, Chairman and CEO of the combined company.

The company will be structured into three business segments - studios, direct-to-consumer and TV media - with Ellison emphasizing the need to expand Paramount's technological capabilities, grow its streaming business and prioritize cash flow.

The merger came at a time when Paramount, like other legacy media players, was struggling with sagging traditional linear TV business as consumers shift to streaming platforms. Paramount took nearly $6 billion in write-downs on cable assets.

The Federal Communications Commission cleared the merger last month, weeks after Paramount settled a lawsuit filed by U.S. President Donald Trump over CBS' editing of a "60 Minutes" interview with his Democratic opponent Kamala Harris.

(Reporting by Deborah Sophia in Bengaluru)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-ehouse Acquires Pointer Creative To Enhance Shopify Creative, UX/UI, Design And Development Capabilities And Expand Its Presence In Apparel, Cosmetics And Beauty
BRIEF-ehouse Acquires Pointer Creative To Enhance Shopify Creative, UX/UI, Design And Development Capabilities And Expand Its Presence In Apparel, Cosmetics And Beauty
Oct 17, 2024
Oct 17 (Reuters) - Ehouse Global Inc ( EHOS ): * EHOUSE ACQUIRES POINTER CREATIVE TO ENHANCE SHOPIFY CREATIVE, UX/UI, DESIGN AND DEVELOPMENT CAPABILITIES AND EXPAND ITS PRESENCE IN APPAREL, COSMETICS AND BEAUTY Source text for Eikon: Further company coverage: ...
BRIEF-Flex To Acquire Crown Technical Systems
BRIEF-Flex To Acquire Crown Technical Systems
Oct 17, 2024
Oct 17 (Reuters) - Flex Ltd ( FLEX ): * FLEX TO ACQUIRE CROWN TECHNICAL SYSTEMS * FLEX LTD ( FLEX ) - TRANSACTION EXPECTED TO BE ACCRETIVE IN FIRST YEAR * FLEX LTD ( FLEX ) - TO ACQUIRE CROWN TECHNICAL SYSTEMS FOR $325 MILLION Source text for Eikon: Further company coverage: ...
BRIEF-Carlisle Companies To Acquire Plasti-Fab, A Canadian Based Vertically Integrated Manufacturer Of Expanded Polystyrene Insulation Products
BRIEF-Carlisle Companies To Acquire Plasti-Fab, A Canadian Based Vertically Integrated Manufacturer Of Expanded Polystyrene Insulation Products
Oct 17, 2024
Oct 17 (Reuters) - Carlisle Companies Inc ( CSL ): * CARLISLE COMPANIES TO ACQUIRE PLASTI-FAB, A CANADIAN BASED VERTICALLY INTEGRATED MANUFACTURER OF EXPANDED POLYSTYRENE INSULATION PRODUCTS * CARLISLE COMPANIES INC ( CSL ) - TO PURCHASE PLASTI-FAB FOR $259.5 MILLION IN CASH * CARLISLE COMPANIES INC ( CSL ) - ACQUISITION TO ADD $0.30 ADJUSTED EPS IN 2025 Source...
Kezar Life Sciences Rejects Concentra Biosciences Takeover Bid, Adopts Rights Plan
Kezar Life Sciences Rejects Concentra Biosciences Takeover Bid, Adopts Rights Plan
Oct 17, 2024
09:11 AM EDT, 10/17/2024 (MT Newswires) -- Kezar Life Sciences ( KZR ) said Thursday that its board of directors has unanimously rejected an unsolicited takeover bid from Concentra Biosciences saying it substantially undervalues the company. The company said Concentra Biosciences sought to acquire all of its outstanding common stock for $1.10 cash per share, as well as the possibility...
Copyright 2023-2026 - www.financetom.com All Rights Reserved